FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Federal Register

Endoscopic Cutting Systems Placed in Class 2

Federal Register notice: FDA classifies the endoscopic electrosurgical clip cutting system into Class 2 (special controls).

Federal Register

Draft Guide on Patient-Focused Drug Development

Federal Register notice: FDA makes available a draft guidance entitled Patient-Focused Drug Development: Collecting Comprehensive and Representative I...

Federal Register

Draft Guide on Humanitarian Device Exemption Program

Federal Register notice: FDA makes available a draft guidance entitled Humanitarian Device Exemption (HDE) Program.

CBER Going to Secure E-Mail

CBER says it will use secure e-mail for regulatory communications with sponsors as of 10/1.

Medical Devices

LivaNovas MEMO 4D Mitral Annuloplasty Ring Cleared

FDA clears a LivaNova 510(k) for its MEMO 4D semi-rigid mitral annuloplasty ring.

Medical Devices

FDA Clears Avanti Widefeild Optical Tomography

FDA clears an Optovue 510(k) for its Avanti Widefield Optical Coherence Tomography system for non-contact, quantitative measurements of the epithelial...

Federal Register

Alternative Mechanisms for Combo Product GMP Compliance

Federal Register notice: FDA issues a proposed list of alternative or streamlined mechanisms for complying with GMP requirements for combination produ...

Federal Register

Guide on Health Care Economic Information Communications

Federal Register notice: FDA makes available a guidance entitled Drug and Device Manufacturer Communications With Payors, Formulary Committees, and Si...

Federal Register

Guide on Medical Product Communications Q & A

Federal Register notice: FDA makes available a guidance for industry entitled Medical Product Communications That Are Consistent With the FDA-Required...

Federal Register

Draft Guide on Limited Population Pathway

Federal Register notice: FDA makes available a draft guidance entitled Limited Population Pathway for Antibacterial and Antifungal Drugs.